Study tracking COVID-19 infection rates in the public
Treatments studied
Part of Infections clinical trials.
This study looks at how often SARS-CoV-2 (the virus that causes COVID-19) infection happens in people who may have been exposed in the community. It may help researchers understand infection rates and patterns in the general population.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were a person in the public who could be exposed to others from May 11, 2020
- You were told about the study by partner institutions
- You are connected to France’s social security system
- You must be able to take part in a clinical study under French rules
- You must not be under legal guardianship or similar legal protection
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects and studies COVID-19 test results and other patient information to better predict treatment response and outcomes. Your sample(s) help researchers understand who may improve, worsen, or need different care.
This study looks closely at how your immune system responds during COVID-19. It may help researchers better understand why COVID-19 varies from person to person and how to improve future care.
This study looks at how the immune system in the body responds to different COVID-19 virus variants. It may help improve how COVID-19 is diagnosed by comparing people who are currently infected and those who are not.
This study collects extra blood or other samples from people who are already getting routine COVID-19 tests or monitoring. The samples are used to better understand how the virus affects the body and to improve future testing.
This study looks at immune (infection-fighting) cells in people who have previously joined certain healthy volunteer research groups. It may help researchers better understand how the immune system responds to coronavirus infections, including COVID-19.
This study follows adults who had COVID-19 to learn how the illness can affect health over the long term. It may help researchers understand lasting symptoms and who is at higher risk, which could improve future care.
Hear when a new Coronavirus Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.